The Indian government is divided about whether to break a patent on a Bristol-Myers Squibb cancer drug called Dasatinib, which is given for leukemia.
WSJ.com: Law, Wall Street Journal: Business: Law
Tue, 11/18/2014 - 2:48am
The Indian government is divided about whether to break a patent on a Bristol-Myers Squibb cancer drug called Dasatinib, which is given for leukemia.